The Study of Ginkgo Leaf Dropping Pills and Huperzine A Injection Combined With Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury

The Study of Ginkgo Leaf Dropping Pills and Huperzine A Injection Combined With Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury

This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.

Specific experimental research methods were randomized, controlled, single-center, exploratory clinical study, through the treatment of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment, to observe the effects of their neuroprotection and cognitive function improvement.

Inclusion Criteria:

• Be over 18 years old
• Residual cognitive impairment due to brain injury
• No previous history of brain-related diseases except this one

Exclusion Criteria:

• The patient had severe underlying disease and unstable vital signs
• The patient was complicated with consciousness disorder and could not cooperate with cognitive function assessment
• Allergic to drugs or contraindications in drug use
• There are contraindications of median nerve electrical stimulation